12924814 C-64 C 64 An Act respecting pharmacare Loi concernant l'assurance médicaments An Act respecting pharmacare Pharmacare Act Loi sur l'assurance médicaments Pharmacare Act 357 Royal assent received Sanction royale reçue Royal assent received 60046 Royal assent Sanction royale Royal assent Royal assent false 2 Senate Sénat Senate 60050 Royal assent Sanction royale Royal assent 60050 Royal assent Sanction royale Royal assent 2 Senate Sénat Senate 2024-10-10T10:40:00 44 1 3 House Government Bill Projet de loi émanant du gouvernement (Cdc) House Government Bill true 1 House of Commons Chambre des communes House of Commons true false 25508 Mark Holland Mark Holland Hon. L’hon. Hon. Minister of Health ministre de la Santé Minister of Health 4 Minister ministre Minister 715 Ajax Ajax Ajax 60149 Royal assent Sanction royale 60050 Royal assent 2024-10-10T14:00:00 2 Senate Sénat Senate 0 0 228 2024-02-29T10:16:57.077 2024-05-07T15:40:00 2024-06-03T19:00:00 2024-06-04T10:15:00 2024-06-18T10:40:00 2024-10-10T10:15:00 2024-10-10T10:40:00 false false true true true true true true true false false 10 Regular Ordinaire Regular <div>A legislative summary is currently being prepared for this bill by the Parliamentary Information, Education and Research Services of the Library of Parliament. Meanwhile, the following executive summary is available.<br/><br/>On 29 February 2024, the Minister of Health introduced Bill C-64, An Act respecting pharmacare (Pharmacare Act), and it was given first reading. <br/><br/>Bill C-64 sets out the principles that the Minister of Health is to consider when working towards the implementation of national universal pharmacare and provides the Minister with the power to make payments, in certain circumstances, in relation to the coverage of certain prescription drugs and related products. It also sets out certain powers and obligations of the Minister — including in relation to the preparation of a list to inform the development of a national formulary and in relation to the development of a national bulk purchasing strategy — and requires the Minister to publish a pan-Canadian strategy regarding the appropriate use of prescription drugs and related products. Finally, it provides for the establishment of a committee of experts to make certain recommendations.</div> <div>Les Service d’information, d’éducation et de recherche parlementaires de la Bibliothèque du Parlement rédige actuellement le résumé législatif de ce projet de loi. Entre-temps, le Service met à votre disposition le sommaire suivant.<br/> <br/>Le 29 février 2024, le ministre de la Santé a déposé le projet de loi C-64, Loi concernant l'assurance médicaments (Loi sur l'assurance médicaments), à la Chambre des communes en première lecture. <br/><br/>Le projet de loi C-64 énonce les principes que le ministre de la Santé prend en compte dans la poursuite du travail vers la mise en œuvre d’un régime d’assurance médicaments national et universel. Il prévoit aussi le pouvoir du ministre d’effectuer des paiements, en certaines circonstances, relativement à la couverture de médicaments sur ordonnance et de produits connexes. Il énonce également certains pouvoirs et certaines obligations de ce ministre, y compris relativement à l’élaboration d’une liste — qui servira de point de départ à l’élaboration d’une liste nationale de médicaments — et à l’élaboration d’une stratégie nationale d’achat en gros, et prévoit l’obligation pour ce ministre de publier une stratégie pancanadienne relative à l’utilisation appropriée des médicaments sur ordonnance et des produits connexes. Enfin, il prévoit la constitution d’un comité d’experts chargé de formuler des recommandations.</div> <div>A legislative summary is currently being prepared for this bill by the Parliamentary Information, Education and Research Services of the Library of Parliament. Meanwhile, the following executive summary is available.<br/><br/>On 29 February 2024, the Minister of Health introduced Bill C-64, An Act respecting pharmacare (Pharmacare Act), and it was given first reading. <br/><br/>Bill C-64 sets out the principles that the Minister of Health is to consider when working towards the implementation of national universal pharmacare and provides the Minister with the power to make payments, in certain circumstances, in relation to the coverage of certain prescription drugs and related products. It also sets out certain powers and obligations of the Minister — including in relation to the preparation of a list to inform the development of a national formulary and in relation to the development of a national bulk purchasing strategy — and requires the Minister to publish a pan-Canadian strategy regarding the appropriate use of prescription drugs and related products. Finally, it provides for the establishment of a committee of experts to make certain recommendations.</div> true 2024 24 0 60029 First reading Première lecture First reading 1 44 1 4 Completed Terminée 2024-02-29T10:16:57.077 Completed Introduction and first reading Dépôt et première lecture Introduction and first reading 288 2024-02-29T00:00:00 true 60110 0 Introduction and first reading Dépôt et première lecture Introduction and first reading 2024-02-29T00:00:00 true false 60110 Introduction and first reading Dépôt et première lecture Introduction and first reading 2024-02-29T10:16:57.077 2024-02-29T10:16:57.077 1 2024-02-29T10:16:57.077 false false 60030 Second reading Deuxième lecture Second reading 1 44 1 4 Completed Terminée 2024-05-07T15:40:00 Completed 0 27190 Standing Committee on Health Comité permanent de la santé HESA Standing Committee on Health 12729090 6 false true false false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 300 2024-04-16T00:00:00 true Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 309 2024-05-06T00:00:00 true Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 310 2024-05-07T00:00:00 true 12723664 12931504 2nd reading and referral to committee - HESA 2e lecture et renvoi en comité - HESA 2nd reading and referral to committee - HESA 15 Agreed To Adoptée Agreed To 10 On recorded division Suivant un vote par appel nominal On recorded division 753 177 148 2 2024-05-07T00:00:00 310 60121 0 Second reading and referral to committee Deuxième lecture et renvoi en comité Second reading and referral to committee 2024-05-07T00:00:00 true false 60121 Second reading and referral to committee Deuxième lecture et renvoi en comité Second reading and referral to committee 2024-05-07T15:40:00 2024-05-07T15:40:00 1 2024-05-07T15:40:00 0 1 12681045 60152 Sponsor’s speech Discours du parrain Sponsor’s speech 25508 Mark Holland Mark Holland Liberal Libéral Liberal 44 1 300 2024-04-16T10:49:08 0 1 12681282 60153 Response speech Discours en réponse Response speech 109905 Stephen Ellis Stephen Ellis Conservative Conservateur Conservative 44 1 300 2024-04-16T11:19:25 0 1 12681801 60153 Response speech Discours en réponse Response speech 88552 Luc Thériault Luc Thériault Bloc Québécois Bloc Québécois Bloc Québécois 44 1 300 2024-04-16T11:51:13 0 1 12682145 60153 Response speech Discours en réponse Response speech 16399 Peter Julian Peter Julian NDP NPD NDP 44 1 300 2024-04-16T12:21:00 false false 60049 Consideration in committee Examen en comité Consideration in committee 1 44 1 4 Completed Terminé 2024-05-28T10:33:54.227 Completed 0 27190 Standing Committee on Health Comité permanent de la santé HESA Standing Committee on Health 12729090 6 false true false false Committee report presented with amendments Présentation du rapport de comité avec des amendements Committee report presented with amendments 319 2024-05-28T00:00:00 true 27190 Standing Committee on Health Comité permanent de la santé HESA 116 2024-05-23T00:00:00 Standing Committee on Health 27190 Standing Committee on Health Comité permanent de la santé HESA 117 2024-05-24T00:00:00 Standing Committee on Health 27190 Standing Committee on Health Comité permanent de la santé HESA 118 2024-05-27T00:00:00 Standing Committee on Health 60124 0 Committee report presented with amendments Présentation du rapport de comité avec des amendements Committee report presented with amendments 2024-05-28T00:00:00 true false 13122750 19 60124 Committee report presented Présentation du rapport de comité Committee report presented 2024-05-28T10:33:54.227 2024-05-28T10:33:54.227 1 2024-05-28T10:33:54.227 false false 60032 Report stage Étape du rapport Report stage 1 44 1 4 Completed Terminée 2024-05-30T23:55:45 Completed Debate at report stage Débat à l’étape du rapport Debate at report stage 322 2024-05-31T00:00:00 true Debate at report stage Débat à l’étape du rapport Debate at report stage 321 2024-05-30T00:00:00 true 60285 0 Concurrence at report stage Adoption à l’étape du rapport Concurrence at report stage 2024-05-30T00:00:00 true false 60285 Concurrence at report stage Adoption à l’étape du rapport Concurrence at report stage 2024-05-30T23:55:45 2024-05-30T23:55:45 1 2024-05-30T23:55:45 false false 60031 Third reading Troisième lecture Third reading 1 44 1 4 Completed Terminée 2024-06-03T19:00:00 Completed Debate at third reading Débat à l’étape de la troisième lecture Debate at third reading 323 2024-06-03T00:00:00 true 12786265 12931506 3rd reading 3e lecture 3rd reading 15 Agreed To Adoptée Agreed To 10 On recorded division Suivant un vote par appel nominal On recorded division 794 165 145 10 2024-06-03T00:00:00 323 60134 0 Third reading Troisième lecture Third reading 2024-06-03T00:00:00 true false 60134 Third reading Troisième lecture Third reading 2024-06-03T19:00:00 2024-06-03T19:00:00 1 2024-06-03T19:00:00 false false 60029 First reading Première lecture First reading 2 44 1 4 Completed Terminée 2024-06-04T10:15:00 Completed First reading Première lecture First reading 207 2024-06-04T00:00:00 false 60111 0 First reading Première lecture First reading 2024-06-04T10:15:00 true false 60111 First reading Première lecture First reading 2024-06-04T10:15:00 2024-06-04T10:15:00 1 2024-06-04T10:15:00 false false 60030 Second reading Deuxième lecture Second reading 2 44 1 4 Completed Terminée 2024-06-18T10:40:00 Completed 0 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI Standing Senate Committee on Social Affairs, Science and Technology false true false false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 209 2024-06-06T00:00:00 false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 210 2024-06-11T00:00:00 false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 211 2024-06-12T00:00:00 false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 212 2024-06-13T00:00:00 false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 214 2024-06-18T00:00:00 false 60120 0 Second reading Deuxième lecture Second reading 2024-06-18T10:40:00 true false 60123 0 Referral to committee Renvoi en comité Referral to committee 2024-06-18T10:45:00 true false 60120 Second reading Deuxième lecture Second reading 2024-06-18T10:40:00 2024-06-18T10:40:00 1 2024-06-18T10:45:00 0 2 60152 Sponsor’s speech Discours du parrain Sponsor’s speech 10310 Kim Pate Kim Pate 207802 Independent Senators Group Groupe des sénateurs indépendants Independent Senators Group 44 1 209 2024-06-06T00:00:00 https://sencanada.ca/en/content/sen/chamber/441/debates/209db_2024-06-06-e#78 https://sencanada.ca/fr/content/sen/chamber/441/debates/209db_2024-06-06-f#78 https://sencanada.ca/en/content/sen/chamber/441/debates/209db_2024-06-06-e#78 0 2 60153 Response speech Discours en réponse Response speech 114671 F. Gigi Osler F. Gigi Osler 227907 Canadian Senators Group Groupe des sénateurs canadiens Canadian Senators Group 44 1 210 2024-06-11T00:00:00 https://sencanada.ca/en/content/sen/chamber/441/debates/210db_2024-06-11-e#63 https://sencanada.ca/fr/content/sen/chamber/441/debates/210db_2024-06-11-f#63 https://sencanada.ca/en/content/sen/chamber/441/debates/210db_2024-06-11-e#63 true false 60049 Consideration in committee Examen en comité Consideration in committee 2 44 1 4 Completed Terminé 2024-10-03T10:10:00 Completed 0 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI Standing Senate Committee on Social Affairs, Science and Technology false true false false Committee report presented without amendment Présentation du rapport de comité sans amendement Committee report presented without amendment 225 2024-10-03T00:00:00 false 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI 110 2024-09-18T00:00:00 Standing Senate Committee on Social Affairs, Science and Technology 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI 111 2024-09-19T00:00:00 Standing Senate Committee on Social Affairs, Science and Technology 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI 112 2024-09-25T00:00:00 Standing Senate Committee on Social Affairs, Science and Technology 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI 113 2024-09-26T00:00:00 Standing Senate Committee on Social Affairs, Science and Technology 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI 114 2024-10-02T00:00:00 Standing Senate Committee on Social Affairs, Science and Technology 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI 115 2024-10-02T00:00:00 Standing Senate Committee on Social Affairs, Science and Technology 16104 Standing Senate Committee on Social Affairs, Science and Technology Comité sénatorial permanent des affaires sociales, des sciences et de la technologie SOCI 116 2024-10-03T00:00:00 Standing Senate Committee on Social Affairs, Science and Technology 60124 0 Committee report presented without amendment Présentation du rapport de comité sans amendement Committee report presented without amendment 2024-10-03T10:10:00 true false 60124 Committee report presented Présentation du rapport de comité Committee report presented 2024-10-03T10:10:00 2024-10-03T10:10:00 1 2024-10-03T11:32:00 false false 60031 Third reading Troisième lecture Third reading 2 44 1 4 Completed Terminée 2024-10-10T10:15:00 Completed Debate at third reading Débat à l’étape de la troisième lecture Debate at third reading 226 2024-10-08T00:00:00 false Debate at third reading Débat à l’étape de la troisième lecture Debate at third reading 227 2024-10-09T00:00:00 false Debate at third reading Débat à l’étape de la troisième lecture Debate at third reading 228 2024-10-10T00:00:00 false 60134 0 Third reading Troisième lecture Third reading 2024-10-10T10:15:00 true false 60134 Third reading Troisième lecture Third reading 2024-10-10T10:15:00 2024-10-10T10:15:00 1 2024-10-10T10:15:00 false false 60050 Royal assent Sanction royale Royal assent 2 44 1 0 Royal assent Sanction royale Royal assent 228 2024-10-10T00:00:00 false 60149 0 Royal assent Sanction royale Royal assent 2024-10-10T10:40:00 true false 60149 Royal assent Sanction royale Royal assent 2024-10-10T10:40:00 2024-10-10T10:40:00 1 2024-10-10T10:40:00 false false 12932378 80701 First Reading Première lecture First Reading 13127922 80702 As amended by committee Tel que modifié par le comité As amended by committee 13153451 80703 As passed by the House of Commons Tel qu’adopté par la Chambre des communes As passed by the House of Commons 13331361 80704 Royal Assent Royal Assent Royal Assent 0 751 Time allocation for Bill C-64, An Act respecting pharmacare Attribution de temps pour le projet de loi C-64, Loi concernant l'assurance médicaments Time allocation for Bill C-64, An Act respecting pharmacare 180 147 0 327 15 Agreed To Adoptée Agreed To 2024-05-06T11:00:00 true false false 0 0 752 2nd reading of Bill C-64, An Act respecting pharmacare (reasoned amendment) 2e lecture du projet de loi C-64, Loi concernant l'assurance médicaments (amendement motivé) 2nd reading of Bill C-64, An Act respecting pharmacare (reasoned amendment) 151 176 2 329 16 Negatived Rejetée Negatived 2024-05-07T10:00:00 false true false 0 0 753 2nd reading of Bill C-64, An Act respecting pharmacare 2e lecture du projet de loi C-64, Loi concernant l'assurance médicaments 2nd reading of Bill C-64, An Act respecting pharmacare 177 148 2 327 15 Agreed To Adoptée Agreed To 2024-05-07T10:00:00 true false false 0 0 791 Bill C-64, An Act respecting pharmacare (report stage amendment) Projet de loi C-64, Loi concernant l'assurance médicaments (amendement à l'étape du rapport) Bill C-64, An Act respecting pharmacare (report stage amendment) 130 169 10 309 16 Negatived Rejetée Negatived 2024-05-30T10:00:00 false true false 0 0 792 Concurrence at report stage of Bill C-64, An Act respecting pharmacare Adoption à l’étape du rapport du projet de loi C-64, Loi concernant l'assurance médicaments Concurrence at report stage of Bill C-64, An Act respecting pharmacare 169 132 10 311 15 Agreed To Adoptée Agreed To 2024-05-30T10:00:00 true false false 0 0 794 3rd reading and adoption of Bill C-64, An Act respecting pharmacare 3e lecture et adoption du projet de loi C-64, Loi concernant l'assurance médicaments 3rd reading and adoption of Bill C-64, An Act respecting pharmacare 165 145 10 320 15 Agreed To Adoptée Agreed To 2024-06-03T11:00:00 true false false 0 0 Government of Canada Passes Legislation for a First Phase of National Universal Pharmacare (2024-10-10 | Department of Health) Le gouvernement du Canada adopte une loi pour une première phase d’un régime national et universel d’assurance médicaments (2024-10-10 | Ministère de la Santé) 5 Press Release Communiqué de presse Press Release https://www.canada.ca/en/health-canada/news/2024/10/government-of-canada-passes-legislation-for-a-first-phase-of-national-universal-pharmacare.html https://www.canada.ca/fr/sante-canada/nouvelles/2024/10/le-gouvernement-du-canada-adopte-une-loi-pour-une-premiere-phase-dun-regime-national-et-universel-dassurance-medicaments.html https://www.canada.ca/en/health-canada/news/2024/10/government-of-canada-passes-legislation-for-a-first-phase-of-national-universal-pharmacare.html 0 Legislative Costing Note: An Act respecting pharmacare (Published 2024-05-15) Note sur l'évaluation du coût d'une mesure législative : Loi concernant l’assurance médicaments (Publié 2024-05-15) 13 Legislative Costing Note Note sur l’évaluation du coût d’une mesure législative Legislative Costing Note https://www.pbo-dpb.ca/en/publications/LEG-2425-003-S--an-act-respecting-pharmacare--loi-concernant-assurance-medicaments https://www.pbo-dpb.ca/fr/publications/LEG-2425-003-S--an-act-respecting-pharmacare--loi-concernant-assurance-medicaments https://www.pbo-dpb.ca/en/publications/LEG-2425-003-S--an-act-respecting-pharmacare--loi-concernant-assurance-medicaments 0 House of Commons, Standing Committee on Health. Pharmacare Now: Prescription Medicine Coverage for all Canadians. Fourteenth Report. 1st Session, 42nd Parliament, April 2018. Chambre des communes, Comité permanent de la santé, Un régime d’assurance-médicaments universel pour tous les Canadiens : une nécessité, quatorzième rapport, 1re session, 42e législature, avril 2018. 8 Related Links Liens connexes Related Links https://www.ourcommons.ca/Content/Committee/421/HESA/Reports/RP9762464/hesarp14/hesarp14-e.pdf https://www.ourcommons.ca/Content/Committee/421/HESA/Reports/RP9762464/hesarp14/hesarp14-f.pdf https://www.ourcommons.ca/Content/Committee/421/HESA/Reports/RP9762464/hesarp14/hesarp14-e.pdf 0 Government highlights next step to universal access to free contraceptives (2024-03-30 | Department of Finance) Le gouvernement annonce la prochaine étape de l’accès universel aux contraceptifs gratuits (2024-03-30 | Ministère des Finances) 5 Press Release Communiqué de presse Press Release https://www.canada.ca/en/department-finance/news/2024/03/government-highlights-next-step-to-universal-access-to-free-contraceptives.html https://www.canada.ca/fr/ministere-finances/nouvelles/2024/03/le-gouvernement-annonce-la-prochaine-etape-de-lacces-universel-aux-contraceptifs-gratuits.html https://www.canada.ca/en/department-finance/news/2024/03/government-highlights-next-step-to-universal-access-to-free-contraceptives.html 0 Charter Statement - Bill C-64: An Act respecting pharmacare (Tabled 2024-05-22) Énoncé concernant la Charte - Projet de loi C-64 : Loi concernant l’assurance médicaments (Déposé 2024-05-22) 7 Background Documents Document(s) d'information Background Documents https://www.justice.gc.ca/eng/csj-sjc/pl/charter-charte/c64.html https://www.justice.gc.ca/fra/sjc-csj/pl/charte-charter/c64.html https://www.justice.gc.ca/eng/csj-sjc/pl/charter-charte/c64.html 0 Government of Canada Introduces Legislation for First Phase of National Universal Pharmacare (2024-02-29 | Department of Health) Le gouvernement du Canada présente un projet de loi pour la mise en œuvre de la première phase d’un régime national et universel d’assurance médicaments (2024-02-29 | Ministère de la Santé) 5 Press Release Communiqué de presse Press Release https://www.canada.ca/en/health-canada/news/2024/02/government-of-canada-introduces-legislation-for-first-phase-of-national-universal-pharmacar.html https://www.canada.ca/fr/sante-canada/nouvelles/2024/02/le-gouvernement-du-canada-presente-un-projet-de-loi-pour-la-mise-en-uvre-de-la-premiere-phase-dun-regime-national-et-universel-dassurance-medicaments.html https://www.canada.ca/en/health-canada/news/2024/02/government-of-canada-introduces-legislation-for-first-phase-of-national-universal-pharmacar.html 0 Universal Access to Contraception (2024-02-29 | Department of Health) Accès universel à la contraception (2024-02-29 | Ministère de la Santé) 7 Background Documents Document(s) d'information Background Documents https://www.canada.ca/en/health-canada/news/2024/02/backgrounder-universal-access-to-contraception.html https://www.canada.ca/fr/sante-canada/nouvelles/2024/02/document-dinformation--acces-universel-a-la-contraception.html https://www.canada.ca/en/health-canada/news/2024/02/backgrounder-universal-access-to-contraception.html 0 Universal Access to Diabetes Medications, and Diabetes Device Fund for Devices and Supplies (2024-02-29 | Department of Health) Accès universel aux médicaments contre le diabète, et Fonds pour les dispositifs et les fournitures pour le traitement du diabète (2024-02-29 | Ministère de la Santé) 7 Background Documents Document(s) d'information Background Documents https://www.canada.ca/en/health-canada/news/2024/02/universal-access-to-diabetes-medications-and-diabetes-device-fund-for-devices-and-supplies.html https://www.canada.ca/fr/sante-canada/nouvelles/2024/02/acces-universel-aux-medicaments-contre-le-diabete-et-fonds-pour-les-dispositifs-et-les-fournitures-pour-le-traitement-du-diabete.html https://www.canada.ca/en/health-canada/news/2024/02/universal-access-to-diabetes-medications-and-diabetes-device-fund-for-devices-and-supplies.html 0 Canada. Department of Health. A Prescription for Canada: Achieving Pharmacare for All. Final Report of the Advisory Council on the Implementation of National Pharmacare. June 2019. Canada. Ministère du Santé. Une ordonnance pour le Canada : l’assurance-médicaments pour tous. Rapport final du Conseil consultatif sur la mise en œuvre d'un régime national d'assurance-médicaments. Juin 2019. 8 Related Links Liens connexes Related Links https://www.canada.ca/en/health-canada/corporate/about-health-canada/public-engagement/external-advisory-bodies/implementation-national-pharmacare/final-report.html https://www.canada.ca/fr/sante-canada/organisation/a-propos-sante-canada/mobilisation-publique/organismes-consultatifs-externes/mise-en-oeuvre-regime-assurance-medicaments/rapport-final.html https://www.canada.ca/en/health-canada/corporate/about-health-canada/public-engagement/external-advisory-bodies/implementation-national-pharmacare/final-report.html 0 Canada. Department of Health. Prescription drug insurance coverage. Canada. Régime d'assurance-médicaments d'ordonnance. 8 Related Links Liens connexes Related Links https://www.canada.ca/en/health-canada/services/health-care-system/pharmaceuticals/access-insurance-coverage-prescription-medicines.html https://www.canada.ca/fr/sante-canada/services/systeme-soins-sante/produits-pharmaceutiques/acces-canadiens-regime-assurance-medicaments-ordonnance.html https://www.canada.ca/en/health-canada/services/health-care-system/pharmaceuticals/access-insurance-coverage-prescription-medicines.html 10635416 C-213 C 213 An Act to enact the Canada Pharmacare Act Loi édictant la Loi canadienne sur l’assurance médicaments An Act to enact the Canada Pharmacare Act Canada Pharmacare Act Loi canadienne sur l'assurance médicaments Canada Pharmacare Act 349 At second reading in the House of Commons À la deuxième lecture à la Chambre des communes At second reading in the House of Commons 60043 First reading Première lecture First reading First reading in the House of Commons false 1 0 60029 First reading Première lecture First reading 1 House of Commons Chambre des communes House of Commons 2020-02-24T15:16:59.66 43 1 0 Private Member’s Bill Projet de loi émanant d'un député Private Member’s Bill false 1 true false 0 0001-01-01T00:00:00 0 0 0 2020-02-24T15:16:59.66 false false true false false false false false false false false 0 false 0 false false 10866059 C-213 C 213 An Act to enact the Canada Pharmacare Act Loi édictant la Loi canadienne sur l’assurance médicaments An Act to enact the Canada Pharmacare Act Canada Pharmacare Act Loi canadienne sur l'assurance médicaments Canada Pharmacare Act 341 Bill defeated Projet de loi rejeté Bill defeated 60043 First reading Première lecture First reading First reading in the House of Commons false 1 0 60029 First reading Première lecture First reading 1 House of Commons Chambre des communes House of Commons 2020-02-24T15:16:59.66 43 2 0 Private Member’s Bill Projet de loi émanant d'un député Private Member’s Bill false 1 true false 0 0001-01-01T00:00:00 0 0 0 false false false false false false false false false false false 0 false 0 false false 12476077 C-340 C 340 An Act to enact the Canada Pharmacare Act Loi édictant la Loi canadienne sur l’assurance médicaments An Act to enact the Canada Pharmacare Act Canada Pharmacare Act Loi canadienne sur l’assurance médicaments Canada Pharmacare Act 360 Outside the Order of Precedence Ne fait pas partie de l'Ordre de priorité Outside the Order of Precedence 60043 First reading Première lecture First reading First reading in the House of Commons false 1 0 60029 First reading Première lecture First reading 1 House of Commons Chambre des communes House of Commons 2023-06-13T10:06:28.1 44 1 0 Private Member’s Bill Projet de loi émanant d'un député Private Member’s Bill false 1 true false 0 0001-01-01T00:00:00 0 0 0 2023-06-13T10:06:28.1 false false true false false false false false false false false 0 false 0 false false false false